When
23 September 2013 – 25 September 2013
Where
Location: World Health Organization headquarters, Geneva, Switzerland
Region: Europe
Objective
The guideline development group is to advise WHO on the following:
-
The interpretation of evidence for establishing cut-offs in serum and red blood cells at the individual at public health level, with explicit consideration of the overall balance of risks and benefits.
-
The formulation of final draft recommendations.
-
Determine the strength of these recommendations, considering the balance of evidence for benefits and harms, and taking into account costs, values and preferences.
-
Define implications for research in the areas discussed.
-
Agree on a ‘review by’ date for the discussed guidelines, considering on-going research and controversies.
